Preclinical efficacy assessment of umbilical cord mesenchymal stem cell therapy for acute liver failure.

hUCMSCs exhibit strong immunomodulatory and hepatoprotective properties in ALF, offering promise for clinical translation. Timing and dosage significantly influence therapeutic efficacy, and cryopreserved cells maintain functionality comparable to that of fresh cells.